These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
208 related articles for article (PubMed ID: 2973542)
1. Differentiating human leukemia cells express heparanase that degrades heparan sulfate in subendothelial extracellular matrix. Yahalom J; Fibach E; Bar-Tana R; Fuks Z; Vlodavsky I Leuk Res; 1988; 12(9):711-7. PubMed ID: 2973542 [TBL] [Abstract][Full Text] [Related]
2. Involvement of both heparanase and plasminogen activator in lymphoma cell-mediated degradation of heparan sulfate in the subendothelial extracellular matrix. Bar-Ner M; Mayer M; Schirrmacher V; Vlodavsky I J Cell Physiol; 1986 Aug; 128(2):299-306. PubMed ID: 2426287 [TBL] [Abstract][Full Text] [Related]
3. Sequential degradation of heparan sulfate in the subendothelial extracellular matrix by highly metastatic lymphoma cells. Bar-Ner M; Kramer MD; Schirrmacher V; Ishai-Michaeli R; Fuks Z; Vlodavsky I Int J Cancer; 1985 Apr; 35(4):483-91. PubMed ID: 3157649 [TBL] [Abstract][Full Text] [Related]
4. Degranulating mast cells secrete an endoglycosidase that degrades heparan sulfate in subendothelial extracellular matrix. Bashkin P; Razin E; Eldor A; Vlodavsky I Blood; 1990 Jun; 75(11):2204-12. PubMed ID: 1693299 [TBL] [Abstract][Full Text] [Related]
5. Thrombin enhances degradation of heparan sulfate in the extracellular matrix by tumor cell heparanase. Benezra M; Vlodavsky I; Bar-Shavit R Exp Cell Res; 1992 Jul; 201(1):208-15. PubMed ID: 1612123 [TBL] [Abstract][Full Text] [Related]
6. Soluble antigen induces T lymphocytes to secrete an endoglycosidase that degrades the heparan sulfate moiety of subendothelial extracellular matrix. Fridman R; Lider O; Naparstek Y; Fuks Z; Vlodavsky I; Cohen IR J Cell Physiol; 1987 Jan; 130(1):85-92. PubMed ID: 2433294 [TBL] [Abstract][Full Text] [Related]
8. Heparanase and a synthetic peptide of heparan sulfate-interacting protein recognize common sites on cell surface and extracellular matrix heparan sulfate. Marchetti D; Liu S; Spohn WC; Carson DD J Biol Chem; 1997 Jun; 272(25):15891-7. PubMed ID: 9188488 [TBL] [Abstract][Full Text] [Related]
9. Murine macrophage heparanase: inhibition and comparison with metastatic tumor cells. Savion N; Disatnik MH; Nevo Z J Cell Physiol; 1987 Jan; 130(1):77-84. PubMed ID: 3805131 [TBL] [Abstract][Full Text] [Related]
10. Expression of heparanase by platelets and circulating cells of the immune system: possible involvement in diapedesis and extravasation. Vlodavsky I; Eldor A; Haimovitz-Friedman A; Matzner Y; Ishai-Michaeli R; Lider O; Naparstek Y; Cohen IR; Fuks Z Invasion Metastasis; 1992; 12(2):112-27. PubMed ID: 1399400 [TBL] [Abstract][Full Text] [Related]
11. Degradation of heparan sulfate in the subendothelial extracellular matrix by a readily released heparanase from human neutrophils. Possible role in invasion through basement membranes. Matzner Y; Bar-Ner M; Yahalom J; Ishai-Michaeli R; Fuks Z; Vlodavsky I J Clin Invest; 1985 Oct; 76(4):1306-13. PubMed ID: 2997275 [TBL] [Abstract][Full Text] [Related]
12. Cell surface localization of heparanase on macrophages regulates degradation of extracellular matrix heparan sulfate. Sasaki N; Higashi N; Taka T; Nakajima M; Irimura T J Immunol; 2004 Mar; 172(6):3830-5. PubMed ID: 15004189 [TBL] [Abstract][Full Text] [Related]
13. Neurotrophin stimulation of human melanoma cell invasion: selected enhancement of heparanase activity and heparanase degradation of specific heparan sulfate subpopulations. Marchetti D; McQuillan DJ; Spohn WC; Carson DD; Nicolson GL Cancer Res; 1996 Jun; 56(12):2856-63. PubMed ID: 8665526 [TBL] [Abstract][Full Text] [Related]
14. Subcellular localization of heparanase in human neutrophils. Matzner Y; Vlodavsky I; Bar-Ner M; Ishai-Michaeli R; Tauber AI J Leukoc Biol; 1992 Jun; 51(6):519-24. PubMed ID: 1613389 [TBL] [Abstract][Full Text] [Related]
15. Maintenance on extracellular matrix and expression of heparanase activity by human ovarian carcinoma cells from biopsy specimens. Peretz T; Antebi SU; Beller U; Horowitz AT; Fuks Z; Vlodavsky I Int J Cancer; 1990 Jun; 45(6):1054-60. PubMed ID: 2190937 [TBL] [Abstract][Full Text] [Related]
16. Translocation of active heparanase to cell surface regulates degradation of extracellular matrix heparan sulfate upon transmigration of mature monocyte-derived dendritic cells. Benhamron S; Nechushtan H; Verbovetski I; Krispin A; Abboud-Jarrous G; Zcharia E; Edovitsky E; Nahari E; Peretz T; Vlodavsky I; Mevorach D J Immunol; 2006 Jun; 176(11):6417-24. PubMed ID: 16709798 [TBL] [Abstract][Full Text] [Related]
17. Neurotrophin stimulation of human melanoma cell invasion: selected enhancement of heparanase activity and heparanase degradation of specific heparan sulfate subpopulations. Marchetti D; Nicolson GL Adv Enzyme Regul; 1997; 37():111-34. PubMed ID: 9381967 [TBL] [Abstract][Full Text] [Related]
18. Specific degradation of subendothelial matrix proteoglycans by brain-metastatic melanoma and brain endothelial cell heparanases. Marchetti D J Cell Physiol; 1997 Sep; 172(3):334-42. PubMed ID: 9284953 [TBL] [Abstract][Full Text] [Related]
19. Inhibition of tumor metastasis by heparanase inhibiting species of heparin. Vlodavsky I; Mohsen M; Lider O; Svahn CM; Ekre HP; Vigoda M; Ishai-Michaeli R; Peretz T Invasion Metastasis; 1994-1995; 14(1-6):290-302. PubMed ID: 7657522 [TBL] [Abstract][Full Text] [Related]